11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping

J Cereb Blood Flow Metab. 1997 Sep;17(9):943-9. doi: 10.1097/00004647-199709000-00003.

Abstract

We compare region of interest (ROI) analytical approaches with statistical parametric mapping (SPM) of 11C-diprenorphine positron emission tomography findings in five patients with Huntington's disease (HD) and nine age-matched controls. The ROI were placed on caudate, putamen, and an occipital reference area. Ratios of striatal-occipital uptake from averaged static images centered at 60 minutes showed a mean 20% reduction in caudate (P = 0.034) and 15% reduction in putamen (P = 0.095) receptor binding in the HD patients. Dynamic data from caudate and putamen ROI, together with a plasma tracer input function, were analyzed using spectral analysis to give regional impulse response functions. Regional data at 60 minutes after impulse showed a mean 29% decrease in caudate (P = 0.006) and 23% decrease in putamen (P = 0.029) opioid binding in the HD cohort. Parametric images of tracer binding also were produced with spectral analysis on a voxel basis. The images of the unit impulse response function at 60 minutes showed a mean 31% decrease in caudate (P = 0.005) and a 26% decrease in putamen binding (P = 0.011) in HD. The voxel-based parametric images were transformed into standard stereotactic space, and a between-group comparison (patient versus controls) was performed with SPM. This approach revealed symmetrical decreases in caudate (peak 40% decrease, z score = 4.38) and putamen opioid binding (peak 24% decrease, z score = 4.686) with additional nonhypothesized changes in cingulate, prefrontal, and thalamic areas. The significance and precision of changes measured with spectral analysis applied to dynamic data sets were superior to ROI-based ratio analysis on static images. The SPM replicated the striatal reductions in opioid binding in HD and detected additional nonpredicted changes. This study suggests that SPM is a valid alternative to conventional ROI analytical approaches for determining binding changes with positron emission tomography and may have advantages over region-based analyses in exploratory studies.

MeSH terms

  • Adult
  • Aged
  • Brain / diagnostic imaging
  • Brain / metabolism*
  • Brain / pathology
  • Diprenorphine / administration & dosage*
  • Female
  • Humans
  • Huntington Disease / diagnostic imaging
  • Huntington Disease / metabolism*
  • Huntington Disease / pathology
  • Male
  • Middle Aged
  • Narcotic Antagonists / administration & dosage*
  • Radiography
  • Receptors, Opioid / analysis
  • Receptors, Opioid / metabolism*
  • Tomography, Emission-Computed

Substances

  • Narcotic Antagonists
  • Receptors, Opioid
  • Diprenorphine